期刊文献+

心房颤动与急性缺血性卒中静脉溶栓致出血转化的相关性及危险因素分析 被引量:16

The correlation between atrial fibrillation and hemorrhagic transformation in patients with acute ischemic stroke after intravenous thrombolysis and the analysis of risk factors
暂未订购
导出
摘要 目的探讨心房颤动与急性缺血性卒中重组组织型纤溶酶原激活剂(rt-PA)静脉溶栓致出血转化的相关性,分析房颤患者溶栓后出血转化的危险因素。方法回顾性分析接受rt-PA静脉溶栓治疗的147例急性缺血性卒中患者,将入选病例分为非房颤组与房颤组,比较两组患者溶栓后出血转化(HT)的差异,采用单因素和logistic回归分析房颤患者溶栓后出血转化的危险因素。结果 147例入组患者中房颤患者66例,非房颤患者81例,房颤组HT与非房颤组比较差异有统计学意义[27.27%(18/66)与14.81%(12/81),χ2=3.071,P=0.028],房颤组症状性HT与非房颤组比较差异亦有统计学意义[12.12%(8/66)与3.70%(3/81),χ2=3.798,P=0.015],logistic回归分析表明伴发房颤的患者基线收缩压高(OR=11.285,95%CI 1.576-68.377,P=0.035)、基线NIHSS评分较高(OR=2.608,95%CI 1.072-4.380,P=0.013)、早期头部CT有缺血改变(OR=1.595,95%CI 1.164-3.258,P=0.023)、起病-溶栓时间(OTT)较长(OR=93.114,95%CI 7.385-177.972,P=0.006)、溶栓24h内血压变异性大(收缩压变异性OR=18.638,95%CI 1.433-65.634,P=0.004;舒张压变异性OR=21.449,95%CI 1.528-56.420,P=0.003)与溶栓后发生HT显著相关。结论房颤与静脉溶栓后HT具有相关性。基线收缩压高、基线NIHSS评分较高、早期头部CT有缺血改变、OTT较长、溶栓24h内血压变异性大是房颤患者静脉溶栓后发生HT的危险因素。 Objective To explore the relation between atrial fibrillation and hemorrhagic transformation(HT) which is the result of the intravenous thrombolysis with recombinant tissue plasminogen activator(rt-PA). To investigate the risk factors for HT after intravenous thrombolysis in patients with atrial fibrillation. Methods 147 patients with acute ischemie stroke after intravenous thrombolysis with rt-PA were consecutively recruited. Patients were divided into the non-fibrillation atrial or fibrillation atrial group. To compare the difference in HT between the two groups. Single factor and logistic regres- sion were used to analyze the risk factors of HT in patients with atrial fibrillation after thrombolytic treatment. Results There were 66 cases with atrial fibrillation in all, and 81 cases were non-atrial fibrillation. The proportions of HT were sig- nificantly different between two groups[ 27.27% (18/66) 与 14.81% ( 12/81 ) ,X2 = 3. 071 ,P = 0. 028 ~, as well as symp- tomatic intracerebral hemorrhage (SICH) [ 12.12% ( 8/66 ) 与 3.70% ( 3/81 ) ,X2 = 3. 798, P = 0.0151. Logistic regression showed high baseline systolic blood pressure ( OR = 11. 285,95% CI 1. 576-68. 377,P = 0. 035 ), high baseline NIHSS score ( OR = 2. 608,95 % CI 1. 072-4. 380, P = 0.013 ), early ischemic changes (EICs) on brain CT ( OR = 1. 595,95 % CI 1.164- 3. 258, P = 0.023 ) , long onset to treatment time (OTF) ( OR = 93.114,95 % C/7. 385-177. 972, P = 0. 006 ) and large blood pressure variability ( systolic pressure variability : OR = 18. 638,95 % CI 1. 433-65. 634, P = 0. 004 ; diastolic pressure varia- bility : OR = 21. 449,95% CI 1. 528-56. 420 ,P = 0. 003 ) were related to HT independently in patients with atrial fibrillation. Conclusion HT after intravenous thrombolysis was relevant to atrial fibrillation. High baseline systolic blood pressure, high baseline NIHSS score, EICs on brain CT, long Oq'T and large blood pressure variability were risk factors for HT after intravenous thrombolvsis in natients with atrial fibrillation.
出处 《中风与神经疾病杂志》 CAS 北大核心 2015年第5期415-418,共4页 Journal of Apoplexy and Nervous Diseases
关键词 缺血性卒中 心房颤动 静脉溶栓 出血转化 危险因素 Ischemic stroke Atrial fibrillation Intravenous thrombolysis Hemorrhagic transformation Risk factors
  • 相关文献

参考文献3

二级参考文献26

  • 1丁宏岩,董强.基底动脉梗死的治疗:动脉和静脉溶栓效果比较的系统分析[J].中国卒中杂志,2006,1(6):414-416. 被引量:128
  • 2冀瑞俊,卢洁,贾建平,马欣,楚长彪.缺血性卒中二例患者溶栓疗效反差的启示[J].中华神经科杂志,2006,39(10):716-717. 被引量:3
  • 3冀瑞俊,贾建平,马欣,楚长彪.“病理生理窗”指导下的溶栓干预模式探讨[J].脑与神经疾病杂志,2007,15(2):89-91. 被引量:17
  • 4Sung PS, Chen CH, Hsieh HC,et al. Outcome of acute ischemic stroke in very elderly patients: is intravenous thrombolysis benef cial? Eur Neurol,2011, 66 : 110-116.
  • 5Nezu T, Koga M, Nakagawara J, et al. Early ischemic change on CT versus diffusion-weighted imaging for patients with stroke receiving intravenous recombinant tissue-type plasminogen activator therapy : stroke acute management with urgent risk-factor assessment and improvement (SAMURAI) rt-PA registry. Stroke, 2011,42:2196-2200.
  • 6Hemmen TM, Rapp KS, Emond JA, et al. Analysis of the national institute of neurological disorders and stroke tissue plasminogen activator studies following European Cooperative Acute Stroke Study Ⅲ patient selection criteria. J StrokeCerebrovasc Dis,2010,19 : 290-293.
  • 7Kidwell CS, Hsia AW, Edwards DF, et al. Racial disparities in tissue plasminogen activator treatment rate for stroke : a population- based study. Stroke, 2011, 42 : 2217-2221.
  • 8Wahlgren N, Ahmed N, Eriksson N, et al. Muhivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials : safe implementation of thrombolysis in stroke-monitoring study (SITS- MOST). Stroke, 2008,39: 3316-3322.
  • 9Montaner J, Molina CA, Monasterio J, et al. Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke. Circulation, 2003, 107: 598.
  • 10Sharma VK, Tsivgoulis G, Tan JH, et al. Feasibility and safety of intravenous thrombolysis in multiethnic Asian stroke patients in Singapore. J Stroke Cerebrovasc Dis, 2010, 12 : 111-134.

共引文献85

同被引文献144

引证文献16

二级引证文献88

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部